Burden of HIV on Society Current Management Options and Future Prospective

Daniel M. Mami *

Department of Sociology, Anthropology and Public Health, University of Maryland, Baltimore County, USA.

Kimberly Morton Cuthrell

Saint James School of Medicine, USA.

Mehrab Manteghian

The University of Buckingham, Hunter Street, Buckingham, MK18 1EG, United Kingdom.

*Author to whom correspondence should be addressed.


Abstract

Nevertheless, there is still a disparity in the availability of antiretroviral therapy (ART), especially in low- and middle-income nations, due to obstacles such as financial constraints, inadequate infrastructure,and on going social stigma. The future outlook for HIV management is optimistic, as current research is dedicated to exploring innovative treatment methods such as long-acting injectable, gene editing medicines, and therapeutic vaccinations. Furthermore, progress in pre-exposure prophylaxis (PrEP) and other preventive measures provide optimism for decreasing the number of new infections. Furthermore, it is crucial to make endeavors towards tackling societal factors that influence health outcomes, such as poverty, education, and gender inequality, as they play a vital role in attaining long-lasting advancements in HIV prevention and care. Notwithstanding these progressions, there are still obstacles to overcome, such as the rise of drug-resistant variations, deficiencies in testing and diagnosis, and enduring social obstacles. To tackle these difficulties, a comprehensive strategy is needed that combines biological, behavioral, and structural interventions, with a focus on fairness and human rights. To reduce the impact of HIV/AIDS on society and achieve the objective of ending the epidemic, it is important to continue investing in research, improving health systems, and promoting collaboration across all sectors.

Keywords: Human immunodeficiency virus, economic productivity loss, encompassing healthcare cost, affecting people's health


How to Cite

Mami , D. M., Cuthrell , K. M., & Manteghian , M. (2024). Burden of HIV on Society Current Management Options and Future Prospective. International STD Research & Reviews, 13(1), 43–62. https://doi.org/10.9734/ISRR/2024/v13i1170

Downloads

Download data is not yet available.

References

Vandergeeten C, et al. Interleukin-7 promotes HIV persistence during antiretroviral therapy. Blood. 2013;121(21): 4321-4329.

Mendoza P, et al. Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir. J Exp Med. 2020;217(7).

Naeli P, et al. The role of MicroRNAs in lung cancer: implications for diagnosis and therapy. Curr Mol Med. 2020;20(2):90-101.

Sadiku MNO. Artificial intelligence. IEEE Potent. 1989;35–39.

Artificial intelligence. Commun ACM. 2017;60(2):10–11.

Luciw PA, Harada S. Virology: overview. AIDS. 1998;12:S1-S3.

Gao F, et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature. 1999;397(6718):436-441.

Sharp PM, Hahn BH. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med. 2011;1(1).

Quinn TC, Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science. 2005;308(5728):1582-1583.

Karim QA, Karim SSA. The evolving HIV epidemic in South Africa. Int J Epidemiol. 2002;31(1):37-40.

Shisana O, Davids A. Correcting gender inequalities is central to controlling HIV/AIDS. SciELO Public Health. 2004; 812-812.

Siegfried N, et al. The Cochrane Library: Male circumcision for prevention of heterosexual acquisition of HIV in men; 2003.

Korenromp E, et al. Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis. 2005;191(Supplement_1): S168-S178.

Bloom SS, et al. Community effects on the risk of HIV infection in rural Tanzania. Sex Transm Infect. 2002;78(4):261-266.

Hayes R, Weiss H. Understanding HIV epidemic trends in Africa. Science. 2006; 311(5761):620-621.

Karim QA, et al. Seroprevalence of HIV infection in rural South Africa. AIDS. 1992; 6(12):1535-1540.

Buchbinder SP, et al. Sexual risk, nitrite inhalant use, and lack of circumcision associated with HIV seroconversion in men who have sex with men in the United States. JAIDS J Acquir Immune Defic Syndr. 2005;39(1):82-89.

Daw M, et al. Dau in association with the Libyan Study Group of Hepatitis & HIV. Seroprevalence of HBV. HCV; 2014.

Blood GAC. Human immunodeficiency virus (HIV). Transfus Med Hemother. 2016; 43(3):203.

Santoro MM, Perno CF. HIV-1 genetic variability and clinical implications. Int Sch Res Notices. 2013;2013.

Tchounga B, et al. Mortality and survival patterns of people living with HIV-2. Curr Opin HIV AIDS. 2016;11(5):537-544.

Désiré N, et al. Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification. Retrovirology. 2018;15: 1-7.

Burke DS. Recombination in HIV: an important viral evolutionary strategy. Emerg Infect Dis. 1997;3(3):253.

Sides TL, et al. HIV-1 subtype diversity in Minnesota. J Infect Dis. 2005;192(1): 37-45.

Tatt ID, et al. The public health significance of HIV-1 subtypes. AIDS. 2001;15:S59-S71.

Akter S, et al. Analytics-based decision-making for service systems: A qualitative study and agenda for future research. Int J Inf Manage. 2019;48.

Akter S, Wamba SF. Big data analytics in E-commerce: A systematic review and agenda for future research. Electron Markets. 2016;26.

Ashwell ML. The digital transformation of intelligence analysis. J Financ Crime. 2017;24.

Davenport TH, Ronanki R. Artificial intelligence for the real world. Harv Bus Rev. 2018;96.

LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521.

World population prospects: the 2002 revision. New York: United Nations; 2002.

Shcherbatova O, et al. Modeling of the HIV-1 Life Cycle in Productively Infected Cells to Predict Novel Therapeutic Targets. Pathogens. 2020;9(4).

Bell C, Devarajan S, Gersbach H. The long-run economic costs of AIDS: A model with an application to South Africa. World Bank Econ Rev. 2006;20(1):55-89.

Kumarasamy N, et al. Financial burden of health services for people with HIV/AIDS in India. Indian J Med Res. 2007;126(6): 509-517.

Duraisamy P, et al. Costs and financial burden of care and support services to PLHA and households in South India. AIDS Care. 2006;18(2):121-127.

Bertozzi S, Forsythe S, Marlink R. The economic impacts of HIV/AIDS on households and economies. 2008.

Abdel-Mohsen M, et al. Human galectin-9 is a potent mediator of HIV transcription and reactivation. PLoS Pathog. 2016; 12(6):e1005677.

De Clercq E, Li G. Approved antiviral drugs over the past 50 years. Clin Microbiol Rev. 2016;29(3):695-747.

Galli L, et al. Burden of disease in PWH harboring a multidrug-resistant virus: data from the PRESTIGIO registry. Open Forum Infect Dis. 2020.

Puertas MC, et al. Pan-resistant HIV-1 emergence in the era of integrase strand-transfer inhibitors: a case report. Lancet Microbe. 2020;1(3):e130-e135.

Ackerman P, et al. Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1. AIDS. 2021;35(7):1061-1072.

Global Burden of Diseases HIV Collaborators. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017. Lancet HIV. 2019;6.

Ayerdi Aguirrebengoa O, et al. Risk factors associated with sexually transmitted infections and HIV among adolescents in a reference clinic in Madrid. PLoS One. 2020;15(2):e0228998.

Beyrer C, et al. The increase in global HIV epidemics in MSM. AIDS. 2013;27(17): 2665-2678.

Eisinger RW, Fauci AS. Ending the HIV/AIDS pandemic. Emerg Infect Dis. 2018;24(3):413-416.

Elgalib A, et al. The epidemiology of HIV in Oman, 1984–2018: a nationwide study from the Middle East. J Epidemiol Glob Health. 2020;10(1):31-37.

Jonas A, et al. HIV prevalence, risk factors for infection, and uptake of prevention, testing, and treatment among female sex workers in Namibia. J Epidemiol Glob Health. 2020;10(1):14-20.

Khan G, Hashim MJ. Burden of virus-associated liver cancer in the Arab world, 1990–2010. Asian Pac J Cancer Prev. 2015;16(6):2657-2662.

Mahy M, et al. HIV estimates through 2018: data for decision-making. AIDS. 2019;33(Suppl 3):S203-S211.

Memish ZA, et al. Knowledge and attitudes about HIV/AIDS in illegal residents in the Kingdom of Saudi Arabia. J Glob Infect Dis. 2015;7(1):8-14.

Murray CJL, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9947):1005-1070.

Sahlu I, et al. HIV status, knowledge of mother-to-child transmission of HIV and antenatal care use among Ethiopian women. J Epidemiol Glob Health. 2014;4(3):177-184.

Nguyen VK, et al. Incidence of sexually transmitted infections before and after preexposure prophylaxis for HIV. AIDS. 2018;32(4):523-530.

Rehle TM, et al. A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One. 2010;5(6):e11094.

Show KL, et al. HIV testing among general population with sexually transmitted infection: findings from Myanmar demographic and health survey (2015–16). J Epidemiol Glob Health. 2020;10(1): 66-71.

Constantine P, Diaz P. Global sensitivity metrics from active subspaces. Reliab Eng Syst Saf. 2017;162:1-11.

Crepaz N, et al. Estimated time from HIV infection to diagnosis and diagnosis to first viral suppression during 2014–2018. AIDS. 2021;35(9):1371-1381.

Diaz P, et al. A modified SEIR model for the spread of Ebola in Western Africa and metrics for resource allocation. Appl Math Comput. 2018;324:218-226.

Hernandez-Vargas EA, Colaneri P, Middleton RH. Switching strategies to mitigate HIV mutation. IEEE Trans Control Syst Technol. 2014;22(3):1024-1032.

Hernandez-Vargas EA, Middleton RH. Modeling the three stages in HIV infection. J Theor Biol. 2013;320:97-107.

Jones E, et al. Analysis and simulation of the three-component model of HIV dynamics. SIURO. 2014;2.

Lau J, et al. Clinical trials of antiretroviral treatment interruption in HIV-infected individuals. AIDS. 2019; 33(14): 2179-2192.

Khandu L, Dhakal GP, Lhazeen K. Baseline CD4 count and the time interval between the initial HIV infection and diagnosis among PLHIV in Bhutan. Immunity, Inflammation and Disease. 2021;9(3):883-890.

Lee F, Amin J, Carr A. Efficacy of initial antiretroviral therapy for HIV-1 infection in adults: a systematic review and meta-analysis of 114 studies with up to 144 weeks’ follow-up. PLoS ONE. 2014;9(5):e97482.

Martinez K, Pankavich S, Brown G. Spatially- heterogeneous embedded stochastic SEIR models for the 2014–2016 Ebola outbreak in West Africa. Spatial Spatio-temporal Epidemiol. 2022;41: 100465.

Reniers G, Armbruster B, Lucas A. Sexual networks, partnership mixing, and the female-to-male ratio of HIV infections in generalized epidemics: An agent-based simulation study. Demographic research. 2015;33:425-450.

UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2012. 2012.

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. N Engl J Med. 1999;340(13):977-987.

Prevention of mother to child transmission of HIV. Indian J Pediatr. 2004;71(2): 161-164.

Ahmed F, Clemens J, Rao M. Community-based evaluation of the effect of breast-feeding on the risk of microbiologically confirmed or clinically presumptive shigellosis Bangladeshi children. J Pediatr. 1992;90(3):406-411.

Jain V, et al. Dynamic handwritten signature and machine learning based identity verification for keyless cryptocurrency transactions. Journal of Discrete Mathematical Sciences and Cryptography. 2019;22(3):441-456.

Karafiloski E, Mishev A. Blockchain solutions for big data challenges: A literature review. In IEEE EUROCON 2017-17th International Conference on Smart Technologies. IEEE. 2017:763–768.

Kim SK, Huh JH. Artificial neural network blockchain techniques for healthcare system: Focusing on the personal health records. Electronics. 2020;9(2):293.

Klinker K, Wiesche M, Krcmar H. Digital transformation in health care: Augmented reality for hands-free service innovation. Information Systems Frontiers. 2019;22(2): 439-454.

Abdulsalam S. Macroeconomic effects of HIV/AIDS prevalence and policy in Nigeria: A simulation analysis. Forum for Health Economics and Policy. 2010;13(1):1-20.

Gezahegn M, Upadhyay M. The effect of HIV/AIDS on economic growth of southern African countries. Asian Economic and Financial Review. 2014;4(9):1191-1205.

Mitchell B, Laws E, Ndhlovu L. Impact of myeloid reservoirs in HIV cure trials. Curr HIV/AIDS Rep. 2019;16(5):375-381.

Pankavich S. The effects of latent infection on the dynamics of HIV. Differ Equ Dyn Syst. 2016;24(3):275-284.

Barouch DH, et al. Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys. Nature. 2013;503(7475): 224-228.

Bruner KM, et al. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature. 2019;566(7742): 120-125.

Eyal N. How to address the risk of HIV transmission in remission studies with treatment interruption: the low-hanging fruit approach. J Infect Dis. 2019;220 (Supplement_1):S76-S79.

Pankavich S, Loudon T. Mathematical analysis and dynamic active subspaces for a long term model of HIV. Math Biosci Eng. 2017;14(2):469-503.

Pankavich S, Neri N, Shutt D. Bistable dynamics and Hopf bifurcation in an early stage model of HIV infection. Discrete Contin Dyn Syst B. 2020;25.

Frange P, et al. HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report. Lancet HIV. 2016;3(1):e49-e54.

Gaillard S, et al. Sustained elite suppression of replication competent HIV-1 in a patient treated with rituximab based chemotherapy. J Clin Virol. 2011;51(3): 195-198.

Pankavich S, Neri N, Shutt D. Bistable dynamics and Hopf bifurcation in an early stage model of HIV infection. Discrete Contin Dyn Syst B. 2020;25(5): 1831-1854.

Xia X. Modelling of HIV infection: vaccine readiness, drug effectiveness and therapeutical failures. J Process Control. 2007;17(2):120-129.

Beardsley J, Hoang NLT, Kibengo FM. Do intracerebral cytokine responses explain the harmful effects of dexamethasone in human immunodeficiency virus-associated cryptococcal meningitis? Clin Infect Dis. 2019;68(4):677-678.

Crowell TA, Gebo KA, Blankson JN. Hospitalization rates among HIV elite controllers and persons with medically controlled HIV infection. J Infect Dis. 2015; 211(11):1692-1702.

Chai Z, et al. Analysis of the efficacy and related factors of ventriculoperitoneal shunt for AIDS with cryptococcal meningitis. Front Surg. 2022;9:802222.

Chang CC, Dorasamy AA, Gosnell BI. Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome. AIDS. 2013;27(13):2089-2099.

Leon A, Perez I, Ruiz-Mateos E. Rate and predictors of progression in elite and viremic HIV-1 controllers. AIDS. 2016; 30(8):1209-1218.

Gunthard HF, Saag MS, Benson CA. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society–USA Panel. JAMA. 2016; 316(2):191-210.

Freund NT, Wang H, Scharf L. Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller. Sci Transl Med. 2017;9(373):eaal2144.

Ellis J, Bangdiwala AS, Cresswell FV. The changing epidemiology of HIV-associated adult meningitis, Uganda 2015–2017. Open Forum Infect Dis. 2019;6(3):ofz105.

Collier AC, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. N Engl J Med. 1996;334(16):1011-1018.

D'Aquila RT, et al. Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996;124(12):1019-1030.

Staszewski S, et al. Virological and immunological analysis of a triple combination pilot study with loviride, lamivudine and zidovudine in HIV-1-infected patients. Aids. 1996;10(5):F1-F7.

Autran B, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science. 1997;277(5322): 112-116.

Komanduri KV, et al. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med. 1998;4(8):953-956.

Lederman MM, et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. Journal of Infectious Diseases, 1998;178(1):70-79.

Ellis J, et al., Cryptococcal meningitis and tuberculous meningitis co-infection in HIV-infected Ugandan adults. Open Forum Infect Dis. 2018;5.

Flynn AG, Meya DB, Hullsiek KH. Evolving failures in the delivery of human immunodeficiency virus care: lessons from a Ugandan meningitis cohort 2006–2016. Open Forum Infect Dis. 2017;4.

Riddell Jt, Amico KR, Mayer KH. HIV Preexposure Prophylaxis: A Review. Jama, 2018;319(12):1261-1268.

Cowan EA, et al., New York State Department of Health AIDS Institute Clinical Guidelines, in Diagnosis and Management of Acute HIV. 2021, Johns Hopkins University Copyright © Johns Hopkins University HIV Clinical Guidelines Program 2000-2020. All Rights Reserved. The use, reproduction, and distribution of original documents and related graphics from this web site is encouraged provided that full credit of source accompanies all uses, in all forms. Please note that if we have adapted or reproduced copyrighted material from another source, with permission, we cannot extend permission to reproduce. Links to pages on this site are also encouraged and may be created without seeking permission.: Baltimore (MD).

Saleska JL, et al., Use of Antiretroviral Therapy During Pregnancy and Adverse Birth Outcomes Among Women Living With HIV-1 in Low- and Middle-Income Countries: A Systematic Review. J Acquir Immune Defic Syndr. 2018; 79(1): 1-9.

O'Donovan, K. and T.I. Emeto, Mother-to-child transmission of HIV in Australia and other high-income countries: Trends in perinatal exposure, demography and uptake of prevention strategies. Aust N Z J Obstet Gynaecol. 2018; 58(5): 499-505.

Choi H, et al., Cost-effectiveness analysis of pre-exposure prophylaxis for the prevention of HIV in men who have sex with men in South Korea: A mathematical modelling study. Scientific Reports. 2020;10.

Choi SK, et al. A multidimensional model of sexual empowerment among young black men who have sex with men: A latent profile analysis. AIDS and Behavior. 2021;25.

Herrick AL, et al. Resilience as a research framework and as a cornerstone of prevention research for gay and bisexual men: Theory and evidence. AIDS and Behavior. 2014;18.

Haddow LJ, et al., Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa. PLoS ONE. 2012;7.

Kim JM, et al. Mode of human immunodeficiency virus transmission in Korea: The Korea HIV/AIDS cohort study. Korean Journal of Medicine. 2019;93.

Moody RL, et al. Internalized homophobia and drug use in a national cohort of gay and bisexual men: Examining depression, sexual anxiety, and gay community attachment as mediating factors. Archives of Sexual Behavior. 2018;47.

Han X, Liu H, Wang Y. A nomogram for predicting paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis among HIV-infected individuals in China. AIDS Res Ther. 2022;19.

Meanley S, et al., Assessing the role of gay community attachment, stigma, and PrEP stereotypes on young men who have sex with men’s PrEP uptake. AIDS and Behavior. 2021;25.

Hommel B, Sturny-Leclère A, Volant S. Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype. PLoS Pathog. 2019;15.

Mulawa MI, et al., mHealth to reduce HIV-related stigma among youth in the United States: A scoping review. Mhealth. 2021;7.

Jarvis JN, Lawrence DS, Meya DB. Single-dose liposomal amphotericin B treatment for cryptococcal meningitis. N Engl J Med. 2022;386.

Visser M, Kotze M, Rensburg MJ. An mHealth HIV prevention programme for youth: Lessons learned from the iloveLife. mobi programme in South Africa. AIDS Care. 2020;32.